MARKET

CDNA

CDNA

Caredx
NASDAQ
10.52
+0.95
+9.93%
Closed 19:19 03/27 EDT
OPEN
9.71
PREV CLOSE
9.57
HIGH
10.54
LOW
9.43
VOLUME
743.14K
TURNOVER
0
52 WEEK HIGH
12.93
52 WEEK LOW
4.800
MARKET CAP
544.71M
P/E (TTM)
-2.9724
1D
5D
1M
3M
1Y
5Y
Weekly Report: what happened at CDNA last week (0318-0322)?
Weekly Report · 3d ago
Weekly Report: what happened at CDNA last week (0311-0315)?
Weekly Report · 03/18 11:06
CareDx Enhances Board with Financial Expert Riggsbee
TipRanks · 03/11 20:13
Weekly Report: what happened at CDNA last week (0304-0308)?
Weekly Report · 03/11 11:03
CareDx Hold Rating: Balancing Modest Growth Prospects with Operational Uncertainties
BTIG analyst Mark Massaro has reiterated their neutral stance on CDNA stock, giving a Hold rating on February 29. CareDx’s fourth-quarter earnings slightly exceeded expectations and the company has a revenue guide for 2024 that surpasses consensus estimates. The company is a transplant diagnostics company.
TipRanks · 03/06 11:25
Weekly Report: what happened at CDNA last week (0226-0301)?
Weekly Report · 03/04 11:06
Friday's ETF Movers: XBI, KRE
NASDAQ · 03/01 17:28
Thursday Sector Laggards: Medical Instruments & Supplies, Diagnostics
NASDAQ · 02/29 16:56
More
About CDNA
CareDx, Inc. is a precision medicine company. The Company is focused on the discovery, development, and commercialization of clinically differentiated, diagnostic solutions for transplant patients and caregivers. The Company offers testing services, products, and patient and digital solutions along the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. Its commercially available testing services consist of AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Its suite of AlloSeq products includes AlloSeq Tx, AlloSeq cfDNA, AlloSeq HCT, TruSight HLA, Olerup SSP and QTYPE. It develops and provides diagnostic surveillance testing services for various transplant recipients.

Webull offers CareDx Inc stock information, including NASDAQ: CDNA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CDNA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CDNA stock methods without spending real money on the virtual paper trading platform.